InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Virax Biolabs Group Ltd

VRAX Clue Score27
United Kingdom Fiscal year ends March CIK 0001885827
$1.85 -1.07% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.85 +523.74% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 21 Jul 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue0.1Operating income−0.6Net income−0.7Fiscal year 2022Revenue0.0 −100.0%Operating income−1.7Net income−1.7EPS, diluted−1.79Fiscal year 2023Revenue0.0Operating income−5.7Net income−5.5EPS, diluted−5.13Fiscal year 2024Revenue0.2 +1,727.1%Operating income−6.5Net income−6.7EPS, diluted−3.36Fiscal year 2025Revenue0.0 −96.0%Operating income−6.2Net income−6.1EPS, diluted−1.62
FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 0.0 0.0 0.2 0.0
Growth −100.0% +1,727.1% −96.0%
Operating income −0.6 −1.7 −5.7 −6.5 −6.2
Net income −0.7 −1.7 −5.5 −6.7 −6.1
Growth
EPS, diluted n/a −1.79 −5.13 −3.36 −1.62

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Gross margin−7.6%Operating margin−520.5%Net margin−525.8%Fiscal year 2022Fiscal year 2023Gross margin−15.9%Operating margin−66,963.7%Net margin−63,748.3%Fiscal year 2024Gross margin32.3%Operating margin−4,153.3%Net margin−4,304.8%Free cash flow margin−4,602.7%Fiscal year 2025Gross margin−838.2%Operating margin−97,344.8%Net margin−95,739.2%Free cash flow margin−81,621.6%
FY2021FY2022FY2023FY2024FY2025
Gross margin −7.6% n/a −15.9% 32.3% −838.2%
Operating margin −520.5% n/a −66,963.7% −4,153.3% −97,344.8%
Net margin −525.8% n/a −63,748.3% −4,304.8% −95,739.2%
Free cash flow margin n/a n/a n/a −4,602.7% −81,621.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−0.6Fiscal year 2022Operating cash flow−0.8Fiscal year 2023Operating cash flow−4.2Fiscal year 2024Operating cash flow−6.2Capital expenditure−1.0Free cash flow−7.2Fiscal year 2025Operating cash flow−4.6Capital expenditure−0.6Free cash flow−5.2
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.6 −0.8 −4.2 −6.2 −4.6
Capital expenditure n/a n/a n/a −1.0 −0.6
Free cash flow n/a n/a n/a −7.2 −5.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash0.0Shareholders’ equity−0.7Fiscal year 2022Cash0.0Shareholders’ equity−1.0Fiscal year 2023Cash9.4Shareholders’ equity9.1Fiscal year 2024Cash3.6Shareholders’ equity5.4Fiscal year 2025Cash4.2Shareholders’ equity5.7
FY2021FY2022FY2023FY2024FY2025
Cash 0.0 0.0 9.4 3.6 4.2
Shareholders’ equity −0.7 −1.0 9.1 5.4 5.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Mar 2021 FY2022† 31 Mar 2022 FY2023 31 Mar 2023 FY2024† 31 Mar 2024 FY2025† 31 Mar 2025
Revenue and profit
0.1 0.0 0.0 0.2 0.0
Growth −100.0% +1,727.1% −96.0%
0.1 n/a 0.0 0.1 0.1
−0.0 n/a −0.0 0.1 −0.1
Growth −204.9%
0.1 0.4 2.2 1.6 1.8
0.5 1.3 3.6 4.6 4.3
−0.6 −1.7 −5.7 −6.5 −6.2
Growth
−0.7 −1.7 −5.5 −6.7 −6.2
n/a n/a n/a n/a −0.1
−0.7 −1.7 −5.5 −6.7 −6.1
Growth
Per share
n/a −1.79 −5.13 −3.36 −1.62
n/a −1.79 −5.13 −3.36 −1.62
Growth
1.6 1.0 1.1 2.0 3.7
1.6 1.0 1.1 2.0 3.7
Growth −39.5% +11.2% +88.8% +85.9%

† The diluted share count jumps at 2022 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 5 of 5 years on file.